Literature DB >> 21333903

The role of diagnostic testing in irritable bowel syndrome.

David L Furman1, Brooks D Cash.   

Abstract

This article discusses the diagnostic criteria and processes applicable to irritable bowel syndrome (IBS). The authors describe the various diagnostic criteria with a focus on the Rome criteria for IBS and the judicious application of historical information such as alarm features and the yield of various diagnostic modalities such as blood, stool, breath, and endoscopic tests. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21333903     DOI： 10.1016/j.gtc.2010.12.001

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  8 in total

1.  Novel Therapies in IBS-D Treatment.

Authors:  Judy Nee; Mohammed Zakari; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

2.  Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic.

Authors:  Duane Charbonneau; Roger D Gibb; Eamonn M M Quigley
Journal:  Gut Microbes       Date:  2013-04-02

Review 3.  Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.

Authors:  Jan Däbritz; Jason Musci; Dirk Foell
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

4.  Human leukocyte antigen DQ2/8 prevalence in non-celiac patients with gastrointestinal diseases.

Authors:  Daniel DiGiacomo; Antonella Santonicola; Fabiana Zingone; Edoardo Troncone; Maria Cristina Caria; Patrizia Borgheresi; Gianpaolo Parrilli; Carolina Ciacci
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

5.  What calprotectin cut-offs should apply for IBD in general practice?

Authors:  Darryl Landis; Pali Hungin; Daniel Hommes
Journal:  Frontline Gastroenterol       Date:  2015-05-18

6.  Irritable bowel syndrome subtype screening characteristics: constipation subtype patient profiles explored.

Authors:  Joyce K Anastasi; Bernadette Capili; Jessica Quinn; Donald J McMahon; Colin Scully
Journal:  Gastroenterol Insights       Date:  2012-07-10

7.  Multiple rather than specific autoantibodies were identified in irritable bowel syndrome with HuProt™ proteome microarray.

Authors:  Wenjuan Fan; Xiucai Fang; Chaojun Hu; Guijun Fei; Qiyun Xiao; Yongzhe Li; Xiaoqing Li; Jackie D Wood; Xuan Zhang
Journal:  Front Physiol       Date:  2022-10-03       Impact factor: 4.755

8.  Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study.

Authors:  Kelly Parsons; Julius Goepp; Bryan Dechairo; Elizabeth Fowler; Nathan Markward; Patrick Hanaway; Teresa McBride; Darryl Landis
Journal:  Glob Adv Health Med       Date:  2014-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.